Pacira BioSciences, Inc.
PCRX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $17.14M | $12.34M | $3.64M | $3.06M |
| Net Income | -$14.03M | -$8.30M | -$8.76M | -$6.81M |
| EPS Diluted | -$0.42 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.51 |
| -$11.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.